DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Companies / Pillar Therapeutics, Inc.
Pillar Therapeutics, Inc.
Stage unknownBoston, MABiotechnology
Facts
Financing history
1 rounds
- Apr 14, 2026Form D equity offering · $14.0M (form d sold) · 2 investorsFact SEC EDGAR Form D data sets (quarterly) · “Pillar Therapeutics, Inc. filed Form D: $14,000,000 sold of $25,000,000, Biotechnology”
Investors on record
0 edges
No named investor yet.
People
2 officers, 2 directors
- Amanda Creedon Executive Officer sec.gov
- Cosmas Giallourakisv Executive Officer/Director/Promoter sec.gov
- Jenna Hebert Director Fact
- Tess Cameron Director Fact
Timeline
1
- May 13, 2026Pillar Therapeutics, Inc. filed Form D: $14,000,000 sold of $25,000,000, BiotechnologyForm D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
15 observations
Every observation on this company
- Entity type: Corporation May 13, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Form D industry group: Biotechnology May 13, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Amendment: false May 13, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Revenue range (Form D): Decline to Disclose May 13, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Incorporated: withinFiveYears May 13, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Jurisdiction: DELAWARE May 13, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Amount sold (Form D): $14.0M May 13, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Offering amount (Form D): $25.0M May 13, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Exemptions: 06b May 13, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- First sale: 2026-04-14 May 13, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Investors (Form D): 2 May 13, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Minimum investment (Form D): 0 May 13, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Securities offered: equity May 13, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Office address: 200 BERKELEY STREET, 18TH FLOOR, BOSTON, MA, 02116 May 13, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Year of incorporation: 2026 May 13, 2026 Fact SEC EDGAR Form D data sets (quarterly)